Interpharm Holdings, Inc.
IPAH · OTC
12/31/2007 | 9/30/2007 | 6/30/2007 | 3/31/2007 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.00 | -0.00 | 0.00 |
| FCF Yield | -2,406.15% | -588.69% | -1,218.50% | -703.11% |
| EV / EBITDA | -13.02 | -6.24 | -4.21 | -10.44 |
| Quality | ||||
| ROIC | -17.09% | -11.19% | -16.32% | -2.89% |
| Gross Margin | 13.99% | 6.07% | 14.83% | 32.02% |
| Cash Conversion Ratio | 0.58 | 0.50 | 0.75 | 2.51 |
| Growth | ||||
| Revenue 3-Year CAGR | 9.46% | 15.78% | 23.72% | 24.47% |
| Free Cash Flow Growth | -38.43% | 51.41% | -37.85% | -65.16% |
| Safety | ||||
| Net Debt / EBITDA | -12.92 | -6.08 | -4.08 | -9.81 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 1.14 | 1.29 | 0.76 | 1.12 |
| Cash Conversion Cycle | 118.26 | 91.40 | 67.22 | 44.43 |